Hospital News and Research

RSS

Personal stories highlight how reform will affect some individuals

News outlets are focusing on the stories of individual consumers to explain how health care reform legislation may affect the lives and health of people around the nation.

8 Dec 2009

Utah project seeks to reduce 'overuse of health care'

News outlets report on a pilot project in Utah to reduce overuse of services and Medicaid cuts in Kansas.

8 Dec 2009

Summa Health System to implement Agilysys' software solution suite

Agilysys, Inc., a leading provider of innovative information technology and hospitality software solutions, announced today that Summa Health System in Akron, Ohio has implemented a comprehensive suite of software solutions to streamline efficiency and control costs in its food outlets and gift shops.

8 Dec 2009

Medicare seeks to cut hospital readmissions with 'Care Transitions' project

The Associated Press reports that a "major push is underway around the country to cut rehospitalizations, in part by arming patients with simple steps to keep their recovery on track," such as getting quicker follow-up doctor visits and lessening medication confusion.

8 Dec 2009

FDA probes excessive radiation dose cases

The Associated Press/Wall Street Journal: "Federal health regulators are investigating reports of dangerous radiation levels at two more California hospitals, following earlier unsafe medical scans at a Los Angeles facility. The Food and Drug Administration is probing the use of CT scans at Glendale Adventist Medical Center and Providence St. Joseph Medical Center in Burbank, Calif. The brain scans are used to diagnose strokes.

8 Dec 2009

Three university academic groups sponsored for the MetaMiner project

GeneGo, Inc., the leading systems biology tools company, announced today that Millipore Corporation has sponsored academic groups from University of Queensland, Sheffield and USC to become members of the collaborative MetaMiner (Stem Cells) project run by GeneGo. MetaMiner is a partnership program for the reconstruction of stem cell pathways and their application in analysis of experimental data as well as knowledge mining.

8 Dec 2009

Moses Cone Health System to implement Streamline Health Solutions' enterprise technology

Streamline Health Solutions, Inc. a leading provider of document workflow solutions for hospitals, today announced that Moses Cone Health System has selected the Company's enterprise technology to improve quality and operating efficiency by providing their physicians with one view of the patient medical record across their healthcare enterprise.

8 Dec 2009

First Edition: December 8, 2009

Today's headlines highlight how Senate consideration of the health bill could become even messier with amendments pending on abortion funding restrictions and the reimportation of prescription drugs. All the while, Senate Dems continue to work to find common ground on the public option.

8 Dec 2009

Clinical trial results of VELCADE based combinations for MM to be presented at the ASH meeting

Millennium: The Takeda Oncology Company today reported the presentation of results from a double randomized Phase III clinical trial of VELCADE based combinations for the treatment of patients with previously untreated multiple myeloma (MM). The VELCADE based combinations evaluated in the study demonstrated two-year overall survival rates ranging between 81 and 88 percent.

8 Dec 2009

Experts attribute increased demand for nursing jobs to rise in pediatric specialty services

A shift upward in the number of children treated by hospitals and outpatient facilities nationwide has created a spike in the demand for pediatric nurses, resulting in high pay and exceptional benefits for these positions.

8 Dec 2009

TSO3 files medical device amendment for the addition of STERIZONE 125L+ Sterilizer

TSO3 Inc. ("TSO3"), an innovator in low temperature sterilization technology for medical devices in healthcare settings through the use of ozone, today announced that it has filed with Health Canada, a medical device amendment for the addition of the STERIZONE(R) 125L+ Sterilizer to the list of already cleared product for sale in Canada.

8 Dec 2009

Consumer Watchdog: Opponents of health reform are fear-mongering relentlessly during Senate debate

Opponents of health reform are fear-mongering relentlessly during prolonged Senate debate, said Consumer Watchdog, spinning endlessly the lobbying messages of the insurance industry.

8 Dec 2009

ASH meeting highlights H1N1 pandemic threat, new trends and treatment options for children with genetic blood disorder

Sickle cell disease, a condition characterized by deformed and dysfunctional red blood cells, is one of the most common genetic blood disorders affecting millions of people around the world, including more than 70,000 Americans (National Heart, Lung, and Blood Institute.

8 Dec 2009

ISST researchers develop software for physicians to have weekly 'Wound Conference'

Wounds suffered by patients with diabetes tend to heal poorly. For treatment to work, the patient's physician must discuss the situation with specialists and nursing staff to decide on the best approach. However, e-mailing the files containing the diagnosis and discussing them on the telephone is a time-consuming process.

8 Dec 2009

Erbitux gaining market share of Avastin in Europe

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, despite its dominance in early lines of metastatic colorectal cancer treatment, Roche/Chugai's Avastin will face increasing competition from Bristol-Myers Squibb/Eli Lilly/Merck KGaA's Erbitux in Germany, France and Spain.

8 Dec 2009

Tranzyme Pharma and Bristol-Myers Squibb sign collaboration agreement

Tranzyme Pharma today announced that it has entered into a strategic collaboration agreement with Bristol-Myers Squibb Company to discover, develop and commercialize novel macrocyclic compounds directed against targets of interest to Bristol-Myers Squibb.

8 Dec 2009

Enrollment of patients for Phase I/IIa clinical study of Interleukin-7 commenced

Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that it has begun enrolling patients in its Phase I/IIa clinical program evaluating the company’s investigative immune-modulator, recombinant human Interleukin-7 (CYT107), in combination with standard antiviral treatment and vaccination in HBeAg-negative chronic hepatitis B-infected (HBV) patients.

8 Dec 2009

Beryl launches H1N1 Risk Assessment service to provide useful information about H1N1 virus

The Beryl Companies, the nation’s leading provider of outsourced call center services for the healthcare industry, has launched a new service that will enhance hospitals’ abilities to provide useful information to consumers who have questions and concerns about the H1N1 virus.

8 Dec 2009

Results of two new studies support the use of intravenous Vimpat for patients in clinical settings

Results of two new studies support the use of the intravenous formulation of the antiepileptic drug (AED) Vimpat® for patients requiring add-on therapy in clinical settings where oral AED therapy is temporarily not feasible.

8 Dec 2009

Cedars-Sinai Regenerative Medicine Institute supplies stem cells to aid Huntington's disease research

The Cedars-Sinai Regenerative Medicine Institute is to provide stem cells to a five-member National Institutes of Health consortium of researchers for development of potential therapies to treat Huntington's disease.

8 Dec 2009

Hospital News and Research

Personal stories highlight how reform will affect some individuals

Utah project seeks to reduce 'overuse of health care'

Summa Health System to implement Agilysys' software solution suite

Medicare seeks to cut hospital readmissions with 'Care Transitions' project

FDA probes excessive radiation dose cases

Three university academic groups sponsored for the MetaMiner project

Moses Cone Health System to implement Streamline Health Solutions' enterprise technology

First Edition: December 8, 2009

Clinical trial results of VELCADE based combinations for MM to be presented at the ASH meeting

Experts attribute increased demand for nursing jobs to rise in pediatric specialty services

TSO3 files medical device amendment for the addition of STERIZONE 125L+ Sterilizer

Consumer Watchdog: Opponents of health reform are fear-mongering relentlessly during Senate debate

ASH meeting highlights H1N1 pandemic threat, new trends and treatment options for children with genetic blood disorder

ISST researchers develop software for physicians to have weekly 'Wound Conference'

Erbitux gaining market share of Avastin in Europe

Tranzyme Pharma and Bristol-Myers Squibb sign collaboration agreement

Enrollment of patients for Phase I/IIa clinical study of Interleukin-7 commenced

Beryl launches H1N1 Risk Assessment service to provide useful information about H1N1 virus

Results of two new studies support the use of intravenous Vimpat for patients in clinical settings

Cedars-Sinai Regenerative Medicine Institute supplies stem cells to aid Huntington's disease research

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News